Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1503) 1503
female (1301) 1301
index medicus (1228) 1228
middle aged (1093) 1093
oncology (1070) 1070
aged (897) 897
surgery (880) 880
adult (786) 786
cancer (765) 765
chemotherapy (654) 654
retrospective studies (615) 615
survival (605) 605
ovarian cancer (602) 602
cytoreduction surgical procedures (572) 572
male (566) 566
ovarian neoplasms - surgery (511) 511
ovarian neoplasms - pathology (498) 498
obstetrics & gynecology (467) 467
prognosis (461) 461
neoplasm staging (444) 444
treatment outcome (417) 417
carcinoma (399) 399
combined modality therapy (391) 391
survival rate (386) 386
cytoreductive surgery (384) 384
cytoreduction surgical procedures - methods (379) 379
peritoneal neoplasms - therapy (375) 375
aged, 80 and over (352) 352
analysis (351) 351
cytoreduction (321) 321
peritoneal neoplasms - secondary (298) 298
antineoplastic combined chemotherapy protocols - therapeutic use (286) 286
medicine & public health (277) 277
follow-up studies (275) 275
care and treatment (269) 269
hematology, oncology and palliative medicine (255) 255
chemotherapy, adjuvant (249) 249
neoadjuvant chemotherapy (246) 246
disease-free survival (239) 239
management (237) 237
hyperthermia, induced (236) 236
metastasis (232) 232
peritoneal neoplasms - surgery (227) 227
hyperthermic intraperitoneal chemotherapy (225) 225
peritoneal carcinomatosis (222) 222
hipec (216) 216
young adult (209) 209
carcinoma, ovarian epithelial (206) 206
morbidity (204) 204
health aspects (199) 199
surgical oncology (197) 197
mortality (196) 196
carcinomatosis (192) 192
ovarian neoplasms - drug therapy (190) 190
ovarian neoplasms - mortality (190) 190
peritoneal neoplasms - mortality (183) 183
obstetrics and gynecology (180) 180
survival analysis (173) 173
peritoneal neoplasms - pathology (170) 170
surgical cytoreduction (169) 169
ovarian neoplasms - therapy (163) 163
neoplasms, glandular and epithelial - surgery (162) 162
neoplasms, glandular and epithelial - pathology (149) 149
neoadjuvant therapy (148) 148
prospective studies (148) 148
hyperthermia, induced - methods (145) 145
research (140) 140
cytoreduction surgical procedures - adverse effects (135) 135
colorectal neoplasms - pathology (134) 134
colorectal-cancer (130) 130
cisplatin (129) 129
tumors (127) 127
adolescent (123) 123
colorectal cancer (122) 122
neoplasm recurrence, local - surgery (120) 120
outcomes (120) 120
patient outcomes (119) 119
medical research (115) 115
neoplasm recurrence, local - pathology (115) 115
risk factors (115) 115
trial (115) 115
antineoplastic agents - administration & dosage (113) 113
antineoplastic agents - therapeutic use (112) 112
chemotherapy, cancer, regional perfusion (112) 112
peritoneal neoplasms - drug therapy (112) 112
complications (110) 110
pseudomyxoma peritonei (109) 109
paclitaxel (107) 107
gynecologic-oncology-group (106) 106
kaplan-meier estimate (106) 106
medicine, experimental (106) 106
resection (104) 104
infusions, parenteral (103) 103
cytoreduction surgical procedures - mortality (102) 102
impact (102) 102
laparoscopy (102) 102
patients (101) 101
systemic chemotherapy (101) 101
metastases (100) 100
origin (96) 96
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1623) 1623
German (18) 18
Korean (6) 6
French (4) 4
Russian (4) 4
Spanish (3) 3
Chinese (2) 2
Hebrew (2) 2
Polish (2) 2
Arabic (1) 1
Bulgarian (1) 1
Danish (1) 1
Hungarian (1) 1
Portuguese (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text A framework for a personalized surgical approach to ovarian cancer
by Nick, Alpa M and Coleman, Robert L and Ramirez, Pedro T and Sood, Anil K
Nature Reviews Clinical Oncology, ISSN 1759-4774, 04/2015, Volume 12, Issue 4, pp. 239 - 245
The standard approach for the treatment of advanced-stage ovarian cancer is upfront cytoreductive surgery followed by a combination of platinum-based and... 
ADVANCED EPITHELIAL OVARIAN | OPTIMAL CYTOREDUCTIVE SURGERY | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | ADVANCED-STAGE OVARIAN | OPTIMAL TUMOR CYTOREDUCTION | PRIMARY DEBULKING SURGERY | COMPUTED-TOMOGRAPHY SCAN | PERITONEAL CARCINOMA | RESIDUAL DISEASE | PREOPERATIVE SERUM CA-125 | Minimally Invasive Surgical Procedures - methods | Humans | Ovarian Neoplasms - pathology | Cytoreduction Surgical Procedures - methods | Neoplasm, Residual | Algorithms | Minimally Invasive Surgical Procedures - standards | Cytoreduction Surgical Procedures - standards | Female | Chemotherapy, Adjuvant | Ovarian Neoplasms - drug therapy | Precision Medicine - methods | Ovarian Neoplasms - surgery | Medicine, Experimental | Medical research | Care and treatment | Ovarian cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma
by Gaujoux, S and Mihai, R and Carnaille, B and Dousset, B and Fiori, C and Porpiglia, F and Hellman, P and Iacobone, M and Kraimps, J.‐L and Donatini, G and Langenhuijsen, J and Lorenz, K and Mathonnet, M and Mirallié, E and Blanchard, C and van Dijkum, E. Nieveen and Raffaelli, M and Rayes, N and Sébag, F and Triponez, F and Valeri, A and Waldmann, J and Zinzindohoue, F and ESES and ENSAT and joint working group of ESES and ENSAT and the joint working group of ESES and ENSAT
British Journal of Surgery, ISSN 0007-1323, 03/2017, Volume 104, Issue 4, pp. 358 - 376
Background Radical surgery provides the best chance of cure for adrenocortical carcinoma (ACC), but perioperative surgical care for these patients is yet to be... 
UNITED-STATES | SURGERY | INFERIOR VENA-CAVA | RIGHT PERIRENAL SPACE | LAPAROSCOPIC ADRENALECTOMY | HOSPITAL VOLUME | PROGNOSTIC-FACTORS | LOCAL RECURRENCE | LONG-TERM SURVIVAL | CORTICAL CARCINOMA | ADJUVANT RADIOTHERAPY | Neoplasms, Multiple Primary - surgery | Physical Examination - methods | Adrenocortical Carcinoma - surgery | Humans | Adrenal Cortex Neoplasms - surgery | Medical Records | Medical History Taking - methods | Tomography, X-Ray Computed - methods | Adrenal Cortex Neoplasms - diagnostic imaging | Lymphatic Metastasis | Cytoreduction Surgical Procedures - methods | Positron-Emission Tomography - methods | Neoplasms, Second Primary - surgery | Neoplasm Recurrence, Local - surgery | Organ Sparing Treatments - methods | Neoplasm Metastasis | Adrenalectomy - methods | Aftercare | Neoplasm Recurrence, Local - diagnostic imaging | Adrenocortical Carcinoma - diagnostic imaging | Referral and Consultation | Lymph Node Excision - methods | Palliative Care - methods | Preoperative Care - methods | Physicians | Carcinoma | Cancer | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
by Heng, Daniel Y.C and Wells, J. Connor and Rini, Brian I and Beuselinck, Benoit and Lee, Jae-Lyun and Knox, Jennifer J and Bjarnason, Georg A and Pal, Sumanta Kumar and Kollmannsberger, Christian K and Yuasa, Takeshi and Srinivas, Sandy and Donskov, Frede and Bamias, Aristotelis and Wood, Lori A and Ernst, D. Scott and Agarwal, Neeraj and Vaishampayan, Ulka N and Rha, Sun Young and Kim, Jenny J and Choueiri, Toni K
European Urology, ISSN 0302-2838, 2014, Volume 66, Issue 4, pp. 704 - 710
Abstract Background The benefit of cytoreductive nephrectomy (CN) for overall survival (OS) is unclear in patients with synchronous metastatic renal cell... 
Urology | Metastatic renal cell carcinoma | Targeted therapy | Cytoreductive nephrectomy | SURVIVAL | INTERFERON-ALPHA | VALIDATION | SUNITINIB | UROLOGY & NEPHROLOGY | MODEL | Neoplasms, Multiple Primary - surgery | Confidence Intervals | Cytoreduction Surgical Procedures - mortality | Follow-Up Studies | Humans | Middle Aged | Carcinoma, Renal Cell - surgery | Male | Antineoplastic Agents - therapeutic use | Nephrectomy - methods | Kidney Neoplasms - surgery | Female | Retrospective Studies | Carcinoma, Renal Cell - drug therapy | Pyrroles - therapeutic use | Molecular Targeted Therapy - methods | Databases, Factual | Neoplasms, Multiple Primary - mortality | Risk Assessment | Carcinoma, Renal Cell - pathology | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Cytoreduction Surgical Procedures - methods | Nephrectomy - mortality | Kidney Neoplasms - mortality | Neoplasms, Multiple Primary - pathology | Carcinoma, Renal Cell - mortality | Disease-Free Survival | Survival Analysis | Indoles - therapeutic use | Kidney Neoplasms - pathology | Aged | Kidney Neoplasms - drug therapy | Neoplasms, Multiple Primary - drug therapy | Hospitals | Metastasis | Carcinoma, Renal cell
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Systemic review and network meta‐analysis comparing minimal surgical techniques for rectal cancer: quality of total mesorectum excision, pathological, surgical, and oncological outcomes
by Rausa, Emanuele and Bianco, Federica and Kelly, Michael E and Aiolfi, Alberto and Petrelli, Fausto and Bonitta, Gianluca and Sgroi, Giovanni
Journal of Surgical Oncology, ISSN 0022-4790, 06/2019, Volume 119, Issue 7, pp. 987 - 998
Background Minimal invasive surgery has revolutionized recovery in rectal cancer patients. However, there has been debate on its effect on quality of total... 
laparoscopic colorectal surgery | robotic colorectal surgery | rectal cancer | total mesorectal excision | SURVIVAL | SURGERY | SHORT-TERM OUTCOMES | TRIALS | RESECTION | CHEMORADIOTHERAPY | LAPAROSCOPIC SURGERY | TME | DIFFERENCE | ONCOLOGY | Minimally Invasive Surgical Procedures - methods | Rectal Neoplasms - surgery | Humans | Treatment Outcome | Cytoreduction Surgical Procedures - methods | Network Meta-Analysis | Randomized Controlled Trials as Topic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Enhanced Recovery After Surgery (ERAS) in gynecologic oncology: System-wide implementation and audit leads to improved value and patient outcomes
by Bisch, S.P and Wells, T and Gramlich, L and Faris, P and Wang, X and Tran, D.T and Thanh, N.X and Glaze, S and Chu, P and Ghatage, P and Nation, J and Capstick, V and Steed, H and Sabourin, J and Nelson, G
Gynecologic Oncology, ISSN 0090-8258, 10/2018, Volume 151, Issue 1, pp. 117 - 123
Enhanced recovery pathways have been shown to reduce length of stay without increasing readmission or complications in numerous areas of surgery. Uptake of... 
Gynecologic oncology | Cost savings | Clinical outcomes | ERAS | COLORECTAL SURGERY | RESECTION | GUIDELINES | PROTOCOL | SOCIETY RECOMMENDATIONS | OVARIAN-CANCER | OBSTETRICS & GYNECOLOGY | ONCOLOGY | ALBERTA | EXPERIENCE | OF-CARE | PROGRAM | Guideline Adherence - statistics & numerical data | Cytoreduction Surgical Procedures - economics | Length of Stay - economics | Gynecologic Surgical Procedures - adverse effects | Humans | Middle Aged | Perioperative Care - economics | Medical Audit | Cost Savings | Gynecologic Surgical Procedures - methods | Patient Discharge - statistics & numerical data | Perioperative Care - standards | Female | Length of Stay - statistics & numerical data | Cytoreduction Surgical Procedures - adverse effects | Gynecologic Surgical Procedures - economics | Patient Readmission - economics | Postoperative Complications - epidemiology | Cytoreduction Surgical Procedures - methods | Genital Neoplasms, Female - surgery | Genital Neoplasms, Female - economics | Perioperative Care - methods | Aged | Program Evaluation | Patient Readmission - statistics & numerical data | Practice Guidelines as Topic | Medicine, Experimental | Medical research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Predictors of optimal cytoreduction in patients with newly diagnosed advanced-stage epithelial ovarian cancer: Time to incorporate laparoscopic assessment into the standard of care
by Gómez-Hidalgo, Natalia Rodriguez and Martinez-Cannon, Bertha Alejandra and Nick, Alpa M and Lu, Karen H and Sood, Anil K and Coleman, Robert L and Ramirez, Pedro T
Gynecologic Oncology, ISSN 0090-8258, 2015, Volume 137, Issue 3, pp. 553 - 558
Abstract The standard management of advanced-stage ovarian cancer has been a subject of debate, and much controversy remains as to whether patients should have... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Surgery | Laparoscopy | Ovarian cancer | SCORE | MANAGEMENT | SUBOPTIMAL CYTOREDUCTION | RESIDUAL DISEASE | EXTERNAL VALIDATION | PREOPERATIVE SERUM CA-125 | OBSTETRICS & GYNECOLOGY | EVALUATE RESECTABILITY | ONCOLOGY | ABILITY | PRIMARY DEBULKING SURGERY | CARCINOMA | Neoplasms, Glandular and Epithelial - pathology | Prospective Studies | Standard of Care | Gynecologic Surgical Procedures - standards | Humans | Ovarian Neoplasms - pathology | Cytoreduction Surgical Procedures - methods | Neoplasms, Glandular and Epithelial - surgery | Gynecologic Surgical Procedures - methods | Laparoscopy - methods | Carcinoma, Ovarian Epithelial | Cytoreduction Surgical Procedures - standards | Female | Laparoscopy - standards | Neoplasm Staging | Ovarian Neoplasms - surgery | Care and treatment | Chemotherapy | Laparoscopic surgery | Health aspects | Cancer | Medical research | Medical colleges | Medicine, Experimental
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Outcomes associated with a five-point surgical site infection prevention bundle in women undergoing surgery for ovarian cancer
by Lippitt, Melissa H and Fairbairn, Melissa Gerardi and Matsuno, Rayna and Stone, Rebecca L and Tanner, Edward J and Wick, Elizabeth C and Angarita, Ana C and Roche, Kara Long and Levinson, Kimberly L and Bergstrom, Jennifer E and Sinno, Abdulrahman K and Curless, Melanie S and Wethington, Stephanie and Temkin, Sarah M and Efron, Jonathan and Hobson, Deborah and Fader, Amanda N
Obstetrics and Gynecology, ISSN 0029-7844, 10/2017, Volume 130, Issue 4, pp. 756 - 764
OBJECTIVE: To identify risk factors for surgical site infection and to define rates associated with cytoreductive surgery before and after implementation of an... 
SURVIVAL | REDUCTION | QUALITY IMPROVEMENT | RESECTION | MECHANICAL BOWEL PREPARATION | ANASTOMOTIC LEAK | CARE SAFETY NETWORK | GYNECOLOGIC CANCER | PROGRAM | ELECTIVE COLORECTAL SURGERY | OBSTETRICS & GYNECOLOGY | Patient Care Bundles - methods | Prospective Studies | Patient Readmission | Humans | Middle Aged | Abdomen - surgery | Cytoreduction Surgical Procedures - standards | Female | Chlorhexidine - administration & dosage | Odds Ratio | Cytoreduction Surgical Procedures - adverse effects | Surgical Wound Infection - epidemiology | Peritoneal Neoplasms - surgery | Antibiotic Prophylaxis - methods | Treatment Outcome | Patient Care Bundles - standards | Cytoreduction Surgical Procedures - methods | Surgical Wound Infection - etiology | Colon - surgery | Antibiotic Prophylaxis - standards | Surgical Wound Infection - prevention & control | Anti-Infective Agents, Local - administration & dosage | Quality Improvement | Fallopian Tube Neoplasms - surgery | Anti-Bacterial Agents - administration & dosage | Ovarian Neoplasms - surgery
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text A novel tumor-specific agent for intraoperative near-infrared fluorescence imaging: A translational study in healthy volunteers and patients with ovarian cancer
by Hoogstins, Charlotte E.S and Tummers, Quirijn R. J. G and Gaarenstroom, Katja N and De Kroon, Cor D and Trimbos, J. Baptist M. Z and Bosse, Tjalling and Smit, Vincent T. H. B. M and Vuyk, Jaap and Van De Velde, Cornelis J. H and Cohen, Adam F and Low, Philip S and Burggraaf, Jacobus and Vahrmeijer, Alexander L
Clinical Cancer Research, ISSN 1078-0432, 06/2016, Volume 22, Issue 12, pp. 2929 - 2938
Purpose: Completeness of cytoreductive surgery is a key prognostic factor for survival in patients with ovarian cancer. The ability to differentiate clearly... 
MACROMOLECULAR THERAPEUTICS | SURVIVAL | CYTOREDUCTIVE SURGERY | METASTASIS | MECHANISM | ONCOLOGY | RESIDUAL DISEASE | EXPRESSION | EPITHELIAL OVARIAN | CHEMOTHERAPY | FOLATE RECEPTOR-ALPHA | Fluorescent Dyes - pharmacokinetics | Neoplasms, Glandular and Epithelial - diagnostic imaging | Neoplasms, Glandular and Epithelial - pathology | Humans | Middle Aged | Ovarian Neoplasms - pathology | Fluorescent Dyes - adverse effects | Male | Cytoreduction Surgical Procedures - methods | Neoplasms, Glandular and Epithelial - surgery | Ovarian Neoplasms - diagnostic imaging | Young Adult | Folate Receptor 1 - metabolism | Adolescent | Carcinoma, Ovarian Epithelial | Adult | Female | Fluorescent Dyes - pharmacology | Aged | Optical Imaging - methods | Ovarian Neoplasms - surgery
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis
by Bristow, Robert E and Puri, Isha and Chi, Dennis S
Gynecologic Oncology, ISSN 0090-8258, 2008, Volume 112, Issue 1, pp. 265 - 274
Abstract Objective To determine the relative effect of multiple prognostic variables on overall post-recurrence survival time among cohorts of patients with... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Recurrence | Cytoreductive surgery | Ovarian cancer | SURVIVAL | GYNECOLOGIC-ONCOLOGY-GROUP | SURGICAL CYTOREDUCTION | PROGNOSTIC-FACTORS | PERITONEAL CARCINOMATOSIS | PLATINUM | CHEMOTHERAPY | OBSTETRICS & GYNECOLOGY | INTRAPERITONEAL CHEMOHYPERTHERMIA | CISPLATIN | ONCOLOGY | SECONDARY CYTOREDUCTION | Female | Neoplasm Recurrence, Local - surgery | Humans | Gynecologic Surgical Procedures - methods | Ovarian Neoplasms - surgery | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text The Survival Advantage of "supratotal" Resection of Glioblastoma Using Selective Cortical Mapping and the Subpial Technique
by Esquenazi, Yoshua and Friedman, Elliott and Liu, Zheyu and Zhu, Jay-Jiguang and Hsu, Sigmund and Tandon, Nitin
Neurosurgery, ISSN 0148-396X, 08/2017, Volume 81, Issue 2, pp. 275 - 288
BACKGROUND: A substantial body of evidence suggests that cytoreductive surgery is a prerequisite to prolonging survival in patients with glioblastoma (GBM).... 
Subpial technique | Carmustine wafer | Supratotal resection | Glioblastoma multiforme | SURGERY | CONTROLLED-TRIAL | GROSS-TOTAL RESECTION | NEWLY-DIAGNOSED GLIOBLASTOMA | RECURRENT GLIOBLASTOMA | BEVACIZUMAB PLUS IRINOTECAN | CLINICAL NEUROLOGY | FLUORESCENCE-GUIDED SURGERY | MALIGNANT GLIOMA | INTRAOPERATIVE MRI GUIDANCE | 5-AMINOLEVULINIC ACID | GRADE II GLIOMAS | Cytoreduction Surgical Procedures - mortality | Humans | Middle Aged | Kaplan-Meier Estimate | Brain Mapping - methods | Cytoreduction Surgical Procedures - methods | Brain Neoplasms - surgery | Glioblastoma - surgery | Neurosurgical Procedures - mortality | Brain Mapping - mortality | Brain - surgery | Neurosurgical Procedures - methods | Retrospective Studies | Brain Neoplasms - mortality | Glioblastoma - mortality | Survival analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer: Analysis and management of complications in upper abdominal surgery
by Benedetti Panici, Pierluigi and Di Donato, Violante and Fischetti, Margherita and Casorelli, Assunta and Perniola, Giorgia and Musella, Angela and Marchetti, Claudia and Palaia, Innocenza and Berloco, Pasquale and Muzii, Ludovico
Gynecologic Oncology, ISSN 0090-8258, 2015, Volume 137, Issue 3, pp. 406 - 411
Abstract Objective To evaluate the complication rate and its impact in patients who have undergone upper abdominal surgery for treatment of advanced ovarian... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Complication rate | Predictors of complication rate | Predictors of postoperative morbidity | Upper abdominal surgery | Advanced ovarian cancer | SURVIVAL | RISK-FACTORS | DISTAL | PERITONEAL | HEPATIC RESECTION | SURGICAL-PROCEDURES | OBSTETRICS & GYNECOLOGY | IMPACT | ONCOLOGY | ADVANCED-STAGE OVARIAN | PULMONARY COMPLICATIONS | PANCREATIC FISTULA | Cytoreduction Surgical Procedures - adverse effects | Postoperative Complications - etiology | Gynecologic Surgical Procedures - adverse effects | Humans | Middle Aged | Ovarian Neoplasms - pathology | Cytoreduction Surgical Procedures - methods | Morbidity | Gynecologic Surgical Procedures - methods | Perioperative Period | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Ovarian Neoplasms - surgery | Postoperative Complications - pathology | Complications and side effects | Analysis | Ovarian cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Letter to the Editor on the "European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery" by Querleu et al, Int J Gynecol Cancer 2016;26: 1354-1363
by Salehi, Sahar and Hjerpe, Elisabet and Falconer, Henrik
International Journal of Gynecological Cancer, ISSN 1048-891X, 03/2018, Volume 28, Issue 3, pp. 426 - 427
ONCOLOGY | OBSTETRICS & GYNECOLOGY | Health Services Accessibility | Ovarian Neoplasms - diagnosis | Gynecologic Surgical Procedures - standards | Humans | Ovarian Neoplasms - pathology | Cytoreduction Surgical Procedures - standards | Female | Cytoreduction Surgical Procedures - methods | Gynecologic Surgical Procedures - methods | Ovarian Neoplasms - surgery | Practice Guidelines as Topic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text En-bloc resection of the pelvis (EnBRP) in patients with stage IIIC–IV ovarian cancer: A 10 steps standardised technique. Surgical and survival outcomes of primary vs. interval surgery
by Tozzi, Roberto and Hardern, Kieran and Gubbala, Kumar and Garruto Campanile, Riccardo and Soleymani majd, Hooman
Gynecologic Oncology, ISSN 0090-8258, 2017, Volume 144, Issue 3, pp. 564 - 570
Abstract Objective In this study we describe the technique of the En-bloc resection of the pelvis (EnBRP) in 10 standardised and reproducible steps, whereby... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Cytoreduction | Complete resection | Ovarian cancer | En-bloc resection | CYTOREDUCTIVE SURGERY | ANASTOMOTIC LEAKAGE | OBSTETRICS & GYNECOLOGY | COLECTOMY | NEOADJUVANT CHEMOTHERAPY | MORBIDITY | ONCOLOGY | RECTOSIGMOID RESECTION | COMPLICATIONS | Pelvis - surgery | Humans | Ovarian Neoplasms - pathology | Survival Analysis | Female | Treatment Outcome | Retrospective Studies | Cytoreduction Surgical Procedures - methods | Ovarian Neoplasms - mortality | Neoplasm Staging | Ovarian Neoplasms - surgery | Care and treatment | Surgery | Patient outcomes | Methods | Chemotherapy | Analysis | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights